Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Clinical trial NCT06059261 · RECRUITING
Trial details
- NCT number
- NCT06059261
- Sponsor
- Chongqing University Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-09
- Primary completion
- 2027-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.